Home
About
Overview
Sharing Data
ORCID
Help
History (60)
Characterization of protein conformational states by normal-mode frequencies.
Noncytotoxic DsRed derivatives for whole-cell labeling.
Delivery of a liposomal c-raf-1 antisense oligonucleotide by weekly bolus dosing in patients with advanced solid tumors: a phase I study.
A phase II study of 9-aminocamptothecin in advanced non-small-cell lung cancer.
Bladder cancer pharmacogenomics: recent insights and future perspectives.
See All 60 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Bladder cancer pharmacogenomics: recent insights and future perspectives.
Bladder cancer pharmacogenomics: recent insights and future perspectives. Pharmacogenomics. 2012 Nov; 13(14):1553-6.
View in:
PubMed
subject areas
Biomarkers, Pharmacological
Cisplatin
DNA-Binding Proteins
Endonucleases
Germ-Line Mutation
Humans
Pharmacogenetics
Tumor Suppressor Protein p53
Urinary Bladder Neoplasms
authors with profiles
Peter O'Donnell